Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger

NCT02145000 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

6586

Enrollment

OTHER

Sponsor class

Conditions

Severe Rotavirus Gastroenteritis

Interventions

BIOLOGICAL: Rotavirus vaccine (BRV-PV)
BIOLOGICAL: Placebo

Sponsor

Epicentre

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]